Grünenthal achieves record 2021 results with double-digit growth and major investments in portfolio and pipeline. Net revenues reached €1.5 billion, an increase of 15 percent over 2020. Adjusted EBITDA reached €370 million, increasing by 10 percent compared to the prior year. Grünenthal's continued strong performance enabled the company to almost triple its adjusted EBITDA since 2017.PR Grünenthal Full-year results 2021
Working at Grünenthal means experiencing the impact you can have on the results we achieve and the lives of the patients we serve.
Make an impact.
Innovate for a world free of pain.